Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
34 active Medicare policies list M31.10, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9
J9 · Effective May 17, 2026
4 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M31.10 |
|---|---|---|
| ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP) | Oct 26, 2023 | Covered |
| Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications | Aug 31, 2023 | Covered |
| Romiplostim (Nplate) | Jan 9, 2024 | Covered |
| Policy | Effective | Status of M31.10 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
JH
JH · Effective May 17, 2026
JL · Effective May 17, 2026
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
National · Effective Jul 1, 2026
National · Effective Jun 8, 2026
National · Effective Jun 8, 2026
J5 · Effective Feb 26, 2026
J5 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026